Asia Pacific AllergyPub Date : 2022-07-29eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e32
Purevsuren Losol, Hee-Sun Park, Woo-Jung Song, Yu-Kyoung Hwang, Sae-Hoon Kim, John W Holloway, Yoon-Seok Chang
{"title":"Association of upper airway bacterial microbiota and asthma: systematic review.","authors":"Purevsuren Losol, Hee-Sun Park, Woo-Jung Song, Yu-Kyoung Hwang, Sae-Hoon Kim, John W Holloway, Yoon-Seok Chang","doi":"10.5415/apallergy.2022.12.e32","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e32","url":null,"abstract":"<p><p>Individual studies have suggested that upper airway dysbiosis may be associated with asthma or its severity. We aimed to systematically review studies that evaluated upper airway bacterial microbiota in relation to asthma, compared to nonasthmatic controls. Searches used MEDLINE, Embase, and Web of Science Core Collection. Eligible studies included association between asthma and upper airway dysbiosis; assessment of composition and diversity of upper airway microbiota using 16S rRNA or metagenomic sequencing; upper airway samples from nose, nasopharynx, oropharynx or hypopharynx. Study quality was assessed and rated using the Newcastle-Ottawa scale. A total of 249 publications were identified; 17 in the final analysis (13 childhood asthma and 4 adult asthma). Microbiome richness was measured in 6 studies, species diversity in 12, and bacterial composition in 17. The quality of evidence was good and fair. The alpha-diversity was found to be higher in younger children with wheezing and asthma, while it was lower when asthmatic children had rhinitis or mite sensitization. In children, Proteobacteria and Firmicutes were higher in asthmatics compared to controls (7 studies), and <i>Moraxella</i>, <i>Streptococcus</i>, and <i>Haemophilus</i> were predominant in the bacterial community. In pooled analysis, nasal <i>Streptococcus</i> colonization was associated with the presence of wheezing at age 5 (<i>p</i> = 0.04). In adult patients with asthma, the abundance of Proteobacteria was elevated in the upper respiratory tract (3 studies). Nasal colonization of <i>Corynebacterium</i> was lower in asthmatics (2 studies). This study demonstrates the potential relationships between asthma and specific bacterial colonization in the upper airway in adult and children with asthma.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e32"},"PeriodicalIF":1.7,"publicationDate":"2022-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/55/apa-12-e32.PMC9353206.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-26eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e31
Alison Joanne Lee, Elizabeth Huiwen Tham, Anne Eng-Neo Goh, Wern-Ee Tang, Yew-Cheong Tung, Yehudi Yeo, Keith Tsou, Le-Ye Lee, Jian-Yi Soh, Cesar Brence Labastida, Ping-Ping Wang, Michelle Mei-Ling Tan, Hsin Yue Cheng, Yiong-Huak Chan, Hugo Van Bever, Lynette Pei-Chi Shek, Bee-Wah Lee
{"title":"Prevalence of IgE-mediated cow milk, egg, and peanut allergy in young Singapore children.","authors":"Alison Joanne Lee, Elizabeth Huiwen Tham, Anne Eng-Neo Goh, Wern-Ee Tang, Yew-Cheong Tung, Yehudi Yeo, Keith Tsou, Le-Ye Lee, Jian-Yi Soh, Cesar Brence Labastida, Ping-Ping Wang, Michelle Mei-Ling Tan, Hsin Yue Cheng, Yiong-Huak Chan, Hugo Van Bever, Lynette Pei-Chi Shek, Bee-Wah Lee","doi":"10.5415/apallergy.2022.12.e31","DOIUrl":"10.5415/apallergy.2022.12.e31","url":null,"abstract":"<p><strong>Background: </strong>The rising prevalence of food allergy reported in the United States, UK, and Australia may be attributable to the rise in peanut allergy prevalence. The food allergy prevalence in other parts of the world such as Asia is, however, less well documented.</p><p><strong>Objective: </strong>This study aimed to evaluate the prevalence of cow's milk, egg, and peanut allergies in a general population of Singaporean children below 30 months of age.</p><p><strong>Methods: </strong>A total of 4,115 children from the general population who attended well-baby visits between 2011 and 2015 completed standardized questionnaires to elicit a convincing history of food allergy to estimate the population prevalence of food allergies.</p><p><strong>Results: </strong>The prevalence of a convincing history of cow's milk allergy was 0.51% (95% confidence interval [CI], 0.3-0.7), hen's egg allergy 1.43% (95% CI, 1.1-1.8), and peanut allergy 0.27% (95% CI, 0.12-0.42). Of the 15 of 59 children with a convincing history of hen's egg allergy who consented, 12 (80%) had corroborative positive skin prick tests.</p><p><strong>Conclusion: </strong>The prevalence of food allergy, in particular peanut allergy, in children below 2 years of age is lower in this South East Asian population than reported in Western cohorts. Further research should focus on deciphering differential risk factors for food allergy across different geographical locations.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e31"},"PeriodicalIF":1.6,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/56/apa-12-e31.PMC9353200.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-22eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e30
João Marcelino, João Vieira, Fátima Ferreira, Irina Didenko, Rute Reis, Rita Silva, Regina Viseu, Elza Tomaz
{"title":"Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine.","authors":"João Marcelino, João Vieira, Fátima Ferreira, Irina Didenko, Rute Reis, Rita Silva, Regina Viseu, Elza Tomaz","doi":"10.5415/apallergy.2022.12.e30","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e30","url":null,"abstract":"<p><p>Stevens-Johnson syndrome is a rare severe delayed-type hypersensitivity reaction. Even though not initially described as a side-effect of the Comirnaty® coronavirus disease 2019 (COVID-19) Vaccine, the worldwide public COVID-19 vaccination programs are uncovering this serious adverse event. We present the case of a 44-year-old woman, vaccinated with the 1st dose in July 2021, and the 2nd dose 4 weeks later. Five days after the 2nd dose, a 10 cm, circular, painful, violet/red lesion appeared on the injection site. From then on, multiple, generalized purpuric painful lesions appeared, associated with ulcers on the lips, oral cavity, nasal cavity, vulva, and vagina, oedema of the hands and feet, conjunctival erythema, blurred vision, and malaise. The patient was being treated with lamotrigine and sodium valproate (for 2 years, without interruptions or dose change) which were stopped, and the patient started treatment with systemic corticosteroids. Lymphocyte transformation test were performed and were positive for PEG2000 1 µg/mL (stimulation index [SI], 30.9), and the undiluted Comirnaty® vaccine (SI, 32.2). These tests were negative on several vaccinated controls. We can definitively show that sensitization to the vaccine and PEG2000 can occur. A more extensive evaluation and reporting is needed to know the true incidence of this life-threatening condition and possible risk factors; as not only further booster shots of this vaccine will be administered, but also new vaccines with the mRNA technology are likely to be more prevalent in the future.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e30"},"PeriodicalIF":1.7,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/34/apa-12-e30.PMC9353208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40413400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Systemic autoinflammatory diseases in pediatric population.","authors":"Maria Luís Marques, Inês Machado Cunha, Sérgio Alves, Margarida Guedes, Carla Zilhão","doi":"10.5415/apallergy.2022.12.e29","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e29","url":null,"abstract":"<p><strong>Background: </strong>Systemic autoinflammatory diseases (SAID) are monogenic and polygenic inherited conditions characterized by dysregulation of the innate immune system.</p><p><strong>Objective: </strong>We aimed to characterize the clinical features of patients with SAID.</p><p><strong>Methods: </strong>This study was a retrospective chart review on the clinical and genetic features of the pediatric population with SAID observed from 1998 to 2020 in our center.</p><p><strong>Results: </strong>A total of 54 patients were evaluated: 18 with periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome; 16 with Behçet disease; 13 with systemic juvenile idiopathic arthritis; 4 with syndrome of undifferentiated recurrent fever; 1 with cryopyrin associated periodic syndrome; 1 with chronic nonbacterial osteomyelitis; and 1 with Muckle-Wells syndrome.</p><p><strong>Conclusion: </strong>The analysis of clinical features of our patients are similar to other studies. Our goal was to aware the medical community to early recognize and treat SAID to improve quality of life of pediatric patients.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e29"},"PeriodicalIF":1.7,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/93/2b/apa-12-e29.PMC9353204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein.","authors":"Jidapa Triwatcharikorn, Jettanong Klaewsongkram, Pawinee Rerknimitr","doi":"10.5415/apallergy.2022.12.e27","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e27","url":null,"abstract":"<p><p>Urticaria is a common cutaneous adverse event from coronavirus disease 2019 vaccination. Previous studies hypothesized that excipients as polyethylene glycol in BNT162b2 vaccine and polysorbate in ChAdOx1 nCoV-19 vaccine are allergens. A 28-year-old woman had urticaria after a booster vaccination with BNT162b2 at the site of previous intradermal injection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) spike protein. This reaction emphasized that delayed urticaria may not be an allergic reaction to excipient but rather to the immunogen as such as SARS-CoV-2 spike protein.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e27"},"PeriodicalIF":1.7,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/c5/apa-12-e27.PMC9353207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40413399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Major basic protein deposited at intra mucosal epithelium with probable eosinophilic chronic rhinosinusitis.","authors":"Satoshi Suzuki, Naomi Kudo, Daisuke Matsushita, Ryutaro Hara, Tomoya Miura, Atsushi Matsubara","doi":"10.5415/apallergy.2022.12.e28","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e28","url":null,"abstract":"<p><strong>Background: </strong>Eosinophilic chronic rhinosinusitis (ECRS) is diagnosed by Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC) scoring system and histopathological eosinophil counts of dissected nasal polyps. Patients with low JESREC score and small number of tissue eosinophils are diagnosed with non-ECRS (NECRS). Due to the 2 parameters of this diagnostic system, chronic rhinosinusitis is to be divided to 4 groups and some patients fall into the 2 groups other than ECRS and NECRS: probable ECRS (pECRS) and probable non-ECRS (pNECRS). We attempted to clarify clinical and histopathological similarities and differences, especially concerning major basic protein (MBP), among those groups.</p><p><strong>Methods: </strong>One hundred twenty-eight patients treated by endoscopic sinus surgery was included. Clinical characteristics were compared among each group, and immunohistological analysis for MBP was performed to 35 randomly selected patients. MBP deposition at intra mucosal epithelium was evaluated by semiquantificational approach.</p><p><strong>Results: </strong>ECRS patients showed significantly higher comorbidity rate with allergic rhinitis (36 patients, 78.3%), asthma (36 patients, 78.3%) compared with other groups. Also, percentage of the patients complaining olfactory dysfunction (42 patients, 91.3%) was significantly higher (<i>p</i> < 0.001). Lund-Mackay score (mean, 14.5; 6-24) and recurrence rate (27 patients, 61.4%) was the highest in ECRS patients. Regarding pECRS, the number of patients with olfactory dysfunction (5 patients, 55.6%) was higher than pNECRS and NECRS groups. Also, comorbidity of asthma and percentage of blood eosinophils tended to be higher than those 2 groups. MBP score of pECRS group was significantly higher than NECRS (<i>p</i> < 0.05), despite of smaller tissue eosinophil counts.</p><p><strong>Conclusion: </strong>pECRS might share some characteristics with ECRS although tissue eosinophil count was significantly smaller compared with ECRS. The results of this study have shown that MBP score in pECRS nasal polyps was significantly higher than NECRS patients and close to ECRS. That might suggest that eosinophils have existed in the nasal polyps of pPECRS patients at some point before surgery.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e28"},"PeriodicalIF":1.7,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/58/apa-12-e28.PMC9353210.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-13eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e26
Jannah Lee S Tarranza, Maria Carmen D Ang
{"title":"The association of CD4 lymphocyte count with drug hypersensitivity reaction to highly active antiretroviral therapy, trimethoprim sulfamethoxazole, and antitubercular agents in human immunodeficiency virus patients.","authors":"Jannah Lee S Tarranza, Maria Carmen D Ang","doi":"10.5415/apallergy.2022.12.e26","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e26","url":null,"abstract":"<p><strong>Background: </strong>The introduction of highly active antiretroviral therapy (HAART) and antibiotic regimens for the treatment of human immunodeficiency virus (HIV) and its concomitant opportunistic infections, respectively, significantly improve the morbidity and mortality of the infected patients. However, these drugs commonly cause drug hypersensitivity reactions (DHRs) in patients with acquired immunodeficiency syndrome. The reason proposed are multifactorial, which includes immune hyperactivation, changes in drug metabolism, patient cytokine profiles, oxidative stress, genetic predisposition, and the principal target in HIV patients, the CD4+ lymphocytes.</p><p><strong>Objective: </strong>This study determined the association of CD4 count and DHRs to first-line HAART, trimethoprim sulfamethoxazole, and antitubercular agents among HIV patients.</p><p><strong>Methods: </strong>This is a retrospective analytical study. Review of charts were done. The demographic and clinical profile used a descriptive statistics such as mean and standard deviation for quantitative data and frequency and percent for categorical data. Chi-square and Fisher exact tests were used to measure the degree of the relationship of CD4 count and DHRs.</p><p><strong>Results: </strong>A total of 337 eligible patients were included. There was a 25% incidence of hypersensitivity reactions. However, the prevalence of DHRs across the different CD4 groups was not statistically significant (<i>p</i> = 0.167). Likewise, the study found no significant association between the CD4 count and DHRs to first-line HAART, trimethoprim sulfamethoxazole, and antitubercular agents (<i>p</i> = 0.311). The most common DHR was morbilliform rash, and nevirapine was the most reported antiretroviral drug causing DHR.</p><p><strong>Conclusion: </strong>There was no association in the CD4 count and DHRs to first-line HAART, trimethoprim sulfamethoxazole, and antitubercular agents. Hence, regardless of the baseline CD4 lymphocyte count, the physician should be vigilant in monitoring hypersensitivity reactions. Patient education on common DHRs is very important upon diagnosis of HIV and/or initiation of treatment.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e26"},"PeriodicalIF":1.7,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/2f/apa-12-e26.PMC9353209.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40413403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-13eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e25
Chang-Keun Kim, Dong Yoon Kang, Zak Callaway, Kyoung Soo Kim, Eun Mi Kwon, Fumiya Yamaide, Taiji Nakano, Yoichi Suzuki, Yoichi Mashimo, Akira Hata, Yoshitaka Okamoto, Naoki Shimojo
{"title":"Increase in eosinophil-derived neurotoxin level in school children with allergic disease.","authors":"Chang-Keun Kim, Dong Yoon Kang, Zak Callaway, Kyoung Soo Kim, Eun Mi Kwon, Fumiya Yamaide, Taiji Nakano, Yoichi Suzuki, Yoichi Mashimo, Akira Hata, Yoshitaka Okamoto, Naoki Shimojo","doi":"10.5415/apallergy.2022.12.e25","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e25","url":null,"abstract":"<p><strong>Background: </strong>Eosinophils are major effector cells of allergic disease and excellent markers of eosinophilic inflammation. Accurate and reliable biomarkers are helpful in the diagnosis, treatment, and control of allergic disease.</p><p><strong>Objective: </strong>This study aimed to investigate an alternate marker of eosinophilic inflammation, eosinophil-derived neurotoxin (EDN), in a number of allergic diseases.</p><p><strong>Methods: </strong>Three hundred ninety-six elementary school-age children with various allergic conditions were recruited for this study. Subgroups included food allergies (FAs), atopic dermatitis (AD), bronchial asthma (BA), and allergic rhinitis (AR). EDN levels in these groups were compared to those in 93 healthy controls (HC).</p><p><strong>Results: </strong>All subjects with allergic disease had elevated levels of serum EDN (median [interquartile range]: FA, 124.2 ng/mL [59.13-160.5 ng/mL]; AD, 110.8 ng/mL [57.52-167.9 ng/mL]; BA, 131.5 ng/mL [60.60-171.0 ng/mL]; AR, 91.32 ng/mL [46.16-145.0 ng/mL]) compared to HC (38.38 ng/mL [32.40-55.62 ng/mL]) (<i>p</i> < 0.0001). These elevated levels were consistent throughout the age range (6-12 years) of the healthy study subjects (<i>p</i> = 0.0679). EDN levels also correlated well with total immunoglobulin E (Rs = 0.5599, <i>p</i> < 0.0001). Looking at all individuals with an allergic disease, the area under the curve was 0.790.</p><p><strong>Conclusions: </strong>Direct measures of eosinophilic inflammation are needed for accurate diagnosis, treatment, and monitoring of allergic diseases. EDN may be a worthy biomarker of eosinophil activity and a useful screening tool for allergic diseases including FA, AD, BA, and AR.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e25"},"PeriodicalIF":1.7,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8d/f4/apa-12-e25.PMC9353201.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-12eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e23
Zhi Xiang Leang, Meera Thalayasingam, Michael O'Sullivan
{"title":"A paediatric case of exercise-augmented anaphylaxis following bee pollen ingestion in Western Australia.","authors":"Zhi Xiang Leang, Meera Thalayasingam, Michael O'Sullivan","doi":"10.5415/apallergy.2022.12.e23","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e23","url":null,"abstract":"<p><p>Bee pollen is becoming an increasingly popular health supplement worldwide due to its many therapeutic applications. Thirteen cases of anaphylaxis to bee pollen consumption have been published to date, with plant pollen of the Compositae family being the most frequently implicated allergen. We present the first known paediatric case of bee pollen anaphylaxis in Australia involving a 15-year-old boy who had a strongly positive skin prick test to the bee pollen consumed where exercise was a possible co-factor. Our patient had a history of allergic rhinitis like most earlier cases. Our patient also had a strongly positive skin prick test to overseas-sourced bee pollen despite no relevant travel history, indicating the likelihood of a common pollen grain or cross-allergenicity of pollen grains found within both bee pollens. Our case reinforces the importance of a careful dietary history including health supplements when assessing for anaphylaxis.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e23"},"PeriodicalIF":1.7,"publicationDate":"2022-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/03/apa-12-e23.PMC9353203.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40697385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Asia Pacific AllergyPub Date : 2022-07-12eCollection Date: 2022-07-01DOI: 10.5415/apallergy.2022.12.e24
Kenny Yat-Choi Kwong, Erica Chen, Paulina Tran, Sydney Leibel, Maryam Masood, Spencer Boyle, Lyne Scott
{"title":"Patterns of allergenic food introduction in Los Angeles inner-city children.","authors":"Kenny Yat-Choi Kwong, Erica Chen, Paulina Tran, Sydney Leibel, Maryam Masood, Spencer Boyle, Lyne Scott","doi":"10.5415/apallergy.2022.12.e24","DOIUrl":"https://doi.org/10.5415/apallergy.2022.12.e24","url":null,"abstract":"<p><strong>Background: </strong>Early introduction of allergenic foods is recommended to reduce the risk of developing food allergies, but it is unclear whether recommendations are being followed.</p><p><strong>Objective: </strong>We examine patterns of allergenic food introduction in inner-city children enrolled in an academic pediatric practice in the greater Los Angeles area.</p><p><strong>Methods: </strong>This was a prospective study with patients ages 12 to 24 months recruited from the pediatrics continuity clinic at an inner-city tertiary medical center in the greater Los Angeles area. Caregivers were asked via anonymous surveys about their child's history of atopic diseases and at what age they first introduced egg, soy, wheat, peanut, tree nuts, fish, shrimp, and shellfish into their child's diet.</p><p><strong>Results: </strong>Two hundred caregivers responded to the survey. The average age of introduction of egg was 9.2 months, soy 10 months, wheat 9.3 months, peanut 10.5 months, tree nuts 10.9 months, fish 10.9 months, shrimp 11.3 months, and shellfish 11.5 months. Between ages 4-11 months, 65.3% of children were introduced egg, 19.1% soy, 55.8% wheat, 28.6% peanut, 17.1% tree nuts, 28.1% fish, 13.6% shrimp, and 7.0% shellfish. By age 24 months, 92% of children were introduced egg, 37.7% soy, 85.4% wheat, 67.3% peanut, 47.7% tree nuts, 67.8% fish, 48.2% shrimp, and 30.2% shellfish. Of the 14 children with eczema or egg allergy, 26.1% were introduced peanut by age 4-6 months and 50% by age 4-11 months.</p><p><strong>Conclusion: </strong>Despite recommendations, inner-city caregivers may not be introducing allergenic foods in a timely manner to their children.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"12 3","pages":"e24"},"PeriodicalIF":1.7,"publicationDate":"2022-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/a6/apa-12-e24.PMC9353202.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40413401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}